From Surf Wiki (app.surf) — the open knowledge base

Intestinal metaplasia

Abnormal transformation of bodily tissue into intestinal tissue

Field	Value
image	Histopathology of Barrett's esophagus, annotated.jpg
caption	Histopathology of Barrett's esophagus, showing intestinalized epithelium with
specialty

Goblet cells, as opposed to normal stratified squamous epithelium of the esophagus, and pseudostratified columnar epithelium of the fundus of the stomach. H&E stain. Intestinal metaplasia is the transformation (metaplasia) of epithelium (usually of the stomach or the esophagus) into a type of epithelium resembling that found in the intestine. In the esophagus, this is called Barrett's esophagus. Chronic inflammation caused by H. pylori infection in the stomach and GERD in the esophagus are seen as the primary instigators of metaplasia and subsequent adenocarcinoma formation. Initially, the transformed epithelium resembles the small intestine lining; in the later stages it resembles the lining of the colon. It is characterized by the appearance of goblet cells and expression of intestinal cell markers such as the transcription factor, CDX2.

Although H. pylori infection can cause gastrointestinal metaplasia, its eradication does not reverse the process. Bile reflux is an additional pathogenic factor in gastrointestinal metaplasia that can continuously irritate the gastric mucosa. Bile acids in refluxed fluid are widely reported to be associated with gastrointestinal metaplasia.

Risk factors

Although it was originally reported that people of East Asian ethnicity with gastric intestinal metaplasia are at increased risk of stomach cancer, it is now clear that gastric intestinal metaplasia is also a risk factor in low-incidence regions like Europe. Risk factors for progression of gastric intestinal metaplasia to full blown cancer are smoking and family history.

Latency

Intestinal metaplasia lesions that have an active DNA damage response are likely to experience extended latency in the premalignant state until the incidence of damages overrides the DNA damage response leading to clonal expansion and progression to cancer. During the DNA damage response, proteins are expressed that detect DNA damages and activate downstream responses like DNA repair, cell cycle checkpoints or apoptosis.

References

(July 2022). "Bile reflux and bile acids in the progression of gastric intestinal metaplasia". Chin Med J (Engl).
(July 2009). "Bile acids as endogenous etiologic agents in gastrointestinal cancer". World J Gastroenterol.
(April 2018). "Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population.". Gastrointestinal Endoscopy.
(April 2019). "Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions". Gut.
(March 2021). "Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions". Endosc Int Open.
(October 2020). "DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.". Gut.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

gastrointestinal-tract-disorders types-of-cancer

Want to explore this topic further?

Ask Mako anything about Intestinal metaplasia — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report